Elevated levels of chylomicron- and VLDL-remnants leads to atherosclerosis in apoE transgenic mice
Van Vlijmen, B.J.; van Ree, J.H.; Frants, R.R.; Hofker, M.H.; Havekes, L.M.
Zeitschrift für Gastroenterologie 34(Suppl 3): 113-115
1996
ISSN/ISBN: 0044-2771 PMID: 8767483 Document Number: 468292
Document emailed within 1 workday
Related Documents
Picarella, D.E.; Kratz, A.; Li, C.B.; Ruddle, N.H.; Flavell, R.A. 1993: Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice Journal of Immunology 150(9): 4136-4150Windler, E.; Greeve, J.; Jäckle, S.; Rinninger, F.; Pox, C.; Puchta, D.; Petkova, D.; Robenek, H.; Daerr, W.; Greten, H. 1996: Endocytic mechanisms for uptake and metabolism of chylomicron remnants in the liver Zeitschrift für Gastroenterologie 34(Suppl 3): 103-104
Zhao, R.; Yao, Y.-y.; Deng, G.; Ju, S.-h.; Wang, Z.-j.; Wen, S.; Chen, J.; Jin, H. 2010: Value of in vivo monitoring of abdominal aortic atherosclerosis by high field magnetic resonance imaging in apoE-/- mice fed a high fat diet or infused with angiotensin Ii Zhonghua Xin Xue Guan Bing Za Zhi 38(9): 823-828
Strath, M.; Dent, L.; Sanderson, C. 1992: Infection of IL5 transgenic mice with Mesocestoides corti induces very high levels of IL5 but depressed production of eosinophils Experimental Hematology 20(2): 229-234
Levin-Allerhand, J.A.; Lominska, C.E.; Smith, J.D. 2002: Increased amyloid- levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet Journal of Nutrition Health and Aging 6(5): 315-319
Berger, G.M.; Van der Westhuyzen, J.H.; Huskisson, J.; Bonnici, F.; Henderson, H.E. 1982: Chylomicron and very-low-density lipoprotein levels in type I hyperlipoproteinaemia. The role of the liver in determining biochemical phenotype South African Medical Journal 61(8): 266-272
Tang, Z.; Zhu, H.; Xia, M.; Hou, M. 2009: Effect of dietary Lactobacillus casei on cholesterol metabolism in apoE-deficient mice Wei Sheng Yan Jiu 38(4): 406-408
Reddy, M.M.; Weissman, A.M.; Mazza, D.S.; Meriney, D.K.; Johns, M.; Carrabis, S.; Grieco, M.H. 1992: Circulating elevated levels of soluble CD23, interleukin-4, and CD20+CD23+ lymphocytes in atopic subjects with elevated serum IgE concentrations Annals of Allergy 69(2): 131-134
Han, W.R.; Zhan, Y.; Murray-Segal, L.J.; Brady, J.L.; Lew, A.M.; Mottram, P.L. 2000: Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice Transplantation 70(1): 168-174
Sarantseva, S.V.; Bol'shakova, O.I.; Timoshenko, S.I.; Rodin, D.I.; Vitek, M.P.; Shvartsman, A.L. 2009: Studying pathogenesis of Alzheimer's disease in a Drosophila melanogaster model: human APP overexpression in the brain of transgenic flies leads to deficit of the synaptic protein synaptotagmin Genetika 45(1): 119-126
Giorgi, J.V.; Liu, Z.; Hultin, L.E.; Cumberland, W.G.; Hennessey, K.; Detels, R. 1993: Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study Journal of Acquired Immune Deficiency Syndromes 6(8): 904-912
Basset-Séguin, N.; Cartier, N.; Demoly, P.; Guilhou, J.J. 1992: Transgenic mice Annales de Dermatologie et de Venereologie 119(8): 597-603
Sandgren, E.P.; Merlino, G. 1995: Hepatocarcinogenesis in transgenic mice Progress in Clinical and Biological Research 391: 213-222
Badiani, P.A.; Kioussis, D.; Swirsky, D.M.; Lampert, I.A.; Weston, K. 1996: T-cell lymphomas in v-Myb transgenic mice Oncogene 13(10): 2205-2212
Peppel, K.; Poltorak, A.; Melhado, I.; Jirik, F.; Beutler, B. 1993: Expression of a TNF inhibitor in transgenic mice Journal of Immunology 151(10): 5699-5703
Ebihara, K.; Ogawa, Y.; Nakao, K. 2002: Insulin resistant transgenic mice Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 8): 79-84
Shvemberger, I.N.; Ginkul, L.B.; Ermilov, A.N. 1994: Leukemia in delta-GAG-MYC transgenic mice Voprosy Onkologii 40(4-6): 198-202
Kay, E.D.; Ross, S.R. 1990: Craniofacial dysmorphogenesis in transgenic mice Journal of Craniofacial Genetics and Developmental Biology 10(1): 63-73
Jäger, R.; Hahne, J.; Jacob, A.; Egert, A.; Schenkel, J.; Wernert, N.; Schorle, H.; Wellmann, A. 2005: Mice transgenic for NPM-ALK develop non-Hodgkin lymphomas Anticancer Research 25(5): 3191-3196
Sidman, C.L.; Shaffer, D.J.; Jacobsen, K.; Vargas, S.R.; Osmond, D.G. 1993: Cell populations during tumorigenesis in Eu-myc transgenic mice Leukemia 7(6): 887-895